1,264
Views
7
CrossRef citations to date
0
Altmetric
Research paper

Overexpression of small nucleolar RNA SNORD1C is associated with unfavorable outcome in colorectal cancer

ORCID Icon, , , , , & ORCID Icon show all
Pages 8943-8952 | Received 21 Jul 2021, Accepted 02 Oct 2021, Published online: 26 Oct 2021

References

  • Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164.
  • Siegel RL, Miller KD, Fuchs HE, et al. 2021. CA Cancer J Clin. 2021;71(1):7–33.
  • DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–271.
  • Welch HG, Robertson DJ. Colorectal Cancer on the Decline–Why Screening Can’t Explain It All. N Engl J Med. 2016;374(17):1605–1607.
  • Maxwell ES, Fournier MJ. The small nucleolar RNAs. Annu Rev Biochem. 1995;64(1):897–934.
  • Dupuis-Sandoval F, Poirier M, Scott MS. The emerging landscape of small nucleolar RNAs in cell biology. Wiley Interdiscip Rev RNA. 2015;6(4):381–397.
  • Cui L, Nakano K, Obchoei S, et al. Small nucleolar noncoding rna snora23, up-regulated in human pancreatic ductal adenocarcinoma, regulates expression of spectrin repeat-containing nuclear envelope 2 to promote growth and metastasis of xenograft tumors in mice. Gastroenterology. 2017;153(1):292–306.e2.
  • Yoshida K, Toden S, Weng W, et al. SNORA21 - An oncogenic small nucleolar RNA, with a prognostic biomarker potential in human colorectal cancer. EBioMedicine. 2017;22:68–77.
  • Li C, Wu L, Liu P, et al. The C/D box small nucleolar RNA SNORD52 regulated by Upf1 facilitates hepatocarcinogenesis by stabilizing CDK1. Theranostics. 2020;10(20):9348–9363.
  • Crea F, Quagliata L, Michael A, et al. Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression. Mol Oncol. 2016;10(5):693–703.
  • Mannoor K, Shen J, Liao J, et al. Small nucleolar RNA signatures of lung tumor-initiating cells. Mol Cancer. 2014;13(1):104.
  • Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res. 2009;7(3):330–338.
  • Tian S, Xing YN, Xia P. The prognostic roles of circulating ALDH1(+) tumor cell in the patients with non-small cell lung cancer. Biosci Rep. 2018;38(5):5.
  • Huang Da W, Bt S, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
  • Huang Da W, Bt S, Ra L. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1–13.
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Issa IA, Noureddine M. Colorectal cancer screening: an updated review of the available options. World J Gastroenterol. 2017;23(28):5086–5096.
  • Chen M, Zhao H. Next-generation sequencing in liquid biopsy: cancer screening and early detection. Hum Genomics. 2019;13(1):34.
  • Rapado-Gonzalez O, Alvarez-Castro A, Lopez-Lopez R, et al. Circulating microRNAs as Promising Biomarkers in Colorectal Cancer. Cancers (Basel). 2019;11(7):898.
  • Marcuello M, Vymetalkova V, Neves RPL, et al. Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol Aspects Med. 2019;69:107–122.
  • Bratkovic T, Bozic J, Rogelj B. Functional diversity of small nucleolar RNAs. Nucleic Acids Res. 2020;48(4):1627–1651.
  • Romano G, Veneziano D, Acunzo M, et al. Small non-coding RNA and cancer. Carcinogenesis. 2017;38(5):485–491.
  • Su J, Liao J, Gao L, et al. Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis. Oncotarget. 2016;7(5):5131–5142.
  • Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer. 2003;3(3):179–192.
  • Cao P, Yang A, Wang R, et al. Germline duplication of SNORA18L5 increases risk for HBV-related hepatocellular carcinoma by altering localization of ribosomal proteins and decreasing levels of p53. Gastroenterology. 2018;155(2):542–556.
  • Li Y, Yu S, Wang X, et al. SRPK1 facilitates tumor cell growth via modulating the small nucleolar RNA expression in gastric cancer. J Cell Physiol. 2019;234(8):13582–13591.
  • Yang X, Li Y, Li L, et al. SnoRNAs are involved in the progression of ulcerative colitis and colorectal cancer. Dig Liver Dis. 2017;49(5):545–551.
  • Zhang Z, Tao Y, Hua Q, et al. SNORA71A promotes colorectal cancer cell proliferation, migration, and invasion. Biomed Res Int. 2020;2020:8284576.